The Valley Desk

Clinical trial reportThe Journal of clinical investigationPublished

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Journal of clinical investigation
Published
Subject terms
Humans; Retinal Diseases; Exodeoxyribonucleases; Phosphoproteins; Adult; Middle Aged; Female; Male; Leukoencephalopathies; Antibodies, Monoclonal, Humanized; retinopathy; Ophthalmology
PubMed ID
38950286
PubMed Central ID
PMC11178534
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal